eurofeedback targeting effective connectivity for chronic low back pain.

Not Applicable

• Conditions: Chronic low back pain; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12623000905662
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-08-23
• Last Update Posted: 28 August 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Participants with a diagnosis of chronic low back pain (CLBP) will be eligible to participate.

Participants will need to:
a) have pain in the lumbar back area that occurs every day for greater than or equal to 3 months,
b) have a score of greater than and equal to 4 on the 11-point numeric pain rating scale (NPRS, 0=No pain to 10=Worst pain) in the past 7 days, and
c) have a disability score of greater than and equal to 5 on Roland–Morris Disability Questionnaire
d) be capable of understanding and signing an informed consent form
e) aged between 18 to 70 years on the day of the consent

Exclusion Criteria

Participants who meet any of the following conditions will be excluded:
•Inflammatory arthritis
•Underwent back surgery in the past 6 months
•Radicular pain and radiculopathy
•Neurological conditions
•Cognitive and psychiatric disorders
•Epilepsy
•Seizures
•Substance abuse
•Pregnant or six-months post-partum

Participants will be permitted to continue their medications for the duration of the trial, with the type and dosage of medication being recorded throughout the duration of the trial. However, participants with the intention of taking new medications in the next three months, will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified